Open original FDA record ↗Recall record
- FDA identifier
- Z-2557-2019
- Company in FDA record
- Randox Laboratories Ltd.
- FDA record creation date
- Sep 23, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Analyte range for Leukocytes for use with the Siemens Multistix method is incorrect. The range was corrected to NEGATIVE to 3+.
Source facts
- Action
- Randox Laboratories notified the distribution center USA by letter dated July 17, 2019 The distributor contacted the customer directly via email on July 25, 2019. The notification states: reason for recall, health risk and action to take: Discard current revision of the Value Sheet and replace with the revised copy available at www.randox.com " Discuss the contents of this notice with your Medical Director. Review results generated with the affected batches in line with the clinical profile of the patient. " Please retain this letter with your laboratory records and forward this letter to those who may have received this product. " Complete and return the response form 12187-QA to technical.services@randox.com within five working days.
- Initiated
- 2019-07-25
- Root cause
- Under Investigation by firm
- Terminated
- 2020-12-03
- Distribution
- US Nationwide distribution including the states of IN, WV.
- Recall number
- Z-2557-2019
- Recall status
- Terminated
- CDRH record ID
- 175807
- FDA record created
- 2019-09-23
- Recall event number
- 83592